Skip to content

Effectiveness of home-based exercise therapy using remotely controlled cycling exercise system in patients with mild cognitive impairment due to non-Alzheimer's disease.

Effectiveness of home-based exercise therapy using remotely controlled cycling exercise system in patients with mild cognitive impairment due to non-Alzheimer's disease. - Effectiveness of remotely controlled cycling exercise system in patients with mild cognitive impairment due to non-Alzheimer's disease.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000053176
Enrollment
45
Registered
2024-01-15
Start date
2024-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild cognitive impairment due to non-Alzheimer&#39

Interventions

Study subjects will receive exercise therapy at home under remote supervision and management. As a general rule, this will be conducted three times a week in a year.

Sponsors

Osaka University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) 65 years of age or older (2) Patient is diagnosed with mild cognitive impairment after a visit to our outpatient neuropsychology clinic of the Department of Neurology and Psychiatry. (3) CSF biomarkers or the results of amyloid PET scan indicate that the patient does not have Alzheimer's pathology. (4) Having a family member living with them or a caregiver who can visit them.

Exclusion criteria

Exclusion criteria: (1) Patients who do not have or cannot establish a reliable Internet environment at home (2) Patients for whom exercise therapy is considered contraindicated (3) Patients who have difficulty pedaling the exercise bike used for exercise therapy due to other diseases or pain (4) Patients who have difficulty operating the application due to visual or hearing impairment (5) Patients who have had hypotension, fatal arrhythmia, or other adverse events during rehabilitation, exercise stress tests, or exercise therapy (6) Patients with acute myocardial infarction leaving untreated significant (>75%) coronary artery stenosis in [AHA classification: #1,2,3,5,6,7,11,13] in the major three branches (7) Patients with end-stage heart failure (8) Patients with evidence of residual myocardial ischemia (9) Patients with poorly controlled heart failure (10) Patients after implantation of left ventricular assist device (11) Patients with a pacemaker, ICD, or implantable cardiac monitor (12) Patients whose prognosis is expected to be within 6 months (13) Patients who have participated in other clinical trials or clinical studies involving interventions within the past 12 weeks of obtaining consent (14) Patients who are judged by the investigators to be incapable of properly understanding the significance of the research and complying with the compliance requirements.

Design outcomes

Primary

MeasureTime frame
The ratio of progression to dementia after 1-year exercise therapy.

Countries

Japan

Contacts

Public ContactTakashi Suehiro

Osaka University Department of Psychiatry

suehiro-takashi@psy.med.osaka-u.ac.jp0668793051

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026